Determination of terbutaline in human plasma by coupled column chromatography
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A method was developed and fully validated for the determination of terbutaline, a β2-receptor agonist, in human plasma. Plasma samples were prepared by solid-phase extraction with Sep-Pak silica, followed by high-performance liquid chromatography (HPLC). The terbutaline was pre-separated from the interfering components in plasma on a Luna C18 (2) column, and terbutaline and salbutamol as an internal standard were resolved and determined on a Luna Silica column. The two columns were connected by a switching valve equipped with silica pre-column. The pre-column was used to concentrate the terbutaline in the eluent from the C18 column before back-flushing onto the silica column with fluorescence detection at an excitation/emission wavelength of 276/306 nm. The method was shown to be specific by testing six different human plasma sources. Linearity was established for a concentration range of 0.4-20.0 ng/mL with a correlation coefficient of 0.9999. The lower limit of quantitation was 0.4 ng/mL with a precision of 10.1% as C.V.%.
Abstract
A method was developed and fully validated for the determination of terbutaline, a β2-receptor agonist, in human plasma. Plasma samples were prepared by solid-phase extraction with Sep-Pak silica, followed by high-performance liquid chromatography (HPLC). The terbutaline was pre-separated from the interfering components in plasma on a Luna C18 (2) column, and terbutaline and salbutamol as an internal standard were resolved and determined on a Luna Silica column. The two columns were connected by a switching valve equipped with silica pre-column. The pre-column was used to concentrate the terbutaline in the eluent from the C18 column before back-flushing onto the silica column with fluorescence detection at an excitation/emission wavelength of 276/306 nm. The method was shown to be specific by testing six different human plasma sources. Linearity was established for a concentration range of 0.4-20.0 ng/mL with a correlation coefficient of 0.9999. The lower limit of quantitation was 0.4 ng/mL with a precision of 10.1% as C.V.%.
참고문헌 (16)
- M. T. Acekrmans, , J. Chromatogr, 590, pp.341~353 (1992)
- G. A. Jacobson, , J. Pharm. Biomed. Anal, 12, pp.825~832 (1994)
- "United States Pharmacopeia (USP30) and National formulary (NF 25)", United State Pharmacopeial Convention, ~ (2007)
- British Pharmacopoeia, "British Pharmacopoeia Commission" (2013), Market Towers
- R. A. Clare, , Biomed. Mass. Spectrom, 6, pp.31~37 (1979)
- S. E. Jacobsson, , Biomed. Mass. Spectrom, 7, pp.265~268 (1980)
- M. Caban, , J. Chromatogr. A, 1281, pp.8110~8122 (2011)
- V. L. Herring, , J. Chromatogr. B, 741, pp.307~312 (2000)
- Y. Q. Xia, , Chirality, 14, pp.742~749 (2002)
- T. Zhou, , Biomed. Chromatogr, 28, pp.994~1002 (2014)
- P. T. McCarthy, , Biomed. Chromatogr, 7, pp.25~28 (1993)
- K. H. Kim, , Arch. Pharm. Res, 23(5), pp.441~445 (2000)
- Y. Arai, , Biomed. Chromatogr, 14, pp.118~124 (2000)
- R. Wyss, , J. Chromatogr. A, 870, pp.189~198 (2000)
- K. H. Kim, , J, Chromatpgr. B, 751, pp.69~77 (2001)
- Y. Zhang, , J. Chromatpgr. B, 805, pp.211~214 (2004)